Better Therapeutics (BTTX) Projected to Announce Earnings on Thursday

Better Therapeutics (NASDAQ:BTTX) is projected to post its results on Thursday, November 12th. Analysts expect Better Therapeutics to announce earnings of ($0.21) per share and revenue of $6.58 million for the quarter.

Better Therapeutics Price Performance

NASDAQ BTTX opened at $0.00 on Wednesday. Better Therapeutics has a 12-month low of $0.00 and a 12-month high of $0.00. The stock has a market cap of $4,058.00, a price-to-earnings ratio of -0.00 and a beta of 0.91.

Better Therapeutics Company Profile

Better Therapeutics was a digital therapeutics company focused on developing prescription software designed to address chronic metabolic and cardiometabolic conditions. Its approach combined behavioral therapy, personalized digital coaching and clinical content delivered through software intended for use alongside standard medical care. The company’s lead product, AspyreRx, formerly known as BT-001, was authorized by the U.S. Food and Drug Administration in 2023 as a prescription digital therapeutic for adults with type 2 diabetes.